baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Santhera Pharmaceuticals Holding .../ CH1276028821 /

5/23/2024 1:55:15 PM	Chg. -	Volume	Bid6:00:04 AM	Ask6:00:04 AM	Market Capitalization	Dividend Y.	P/E Ratio
9.440CHF	-	1 Turnover: 9.440	-Bid Size: -	-Ask Size: -	124.94 mill.CHF	-	2.28

GlobeNewswire 2:00 PM Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of ...

GlobeNewswire 2:00 PM Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored...

GlobeNewswire 1:30 PM Intellia Therapeutics Names Brian Goff to its Board of Directors

GlobeNewswire 1:00 PM TScan Therapeutics Announces Updates to its Board of Directors

GlobeNewswire 9:00 AM Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...

GlobeNewswire 3:00 AM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...

GlobeNewswire 6/13 Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

GlobeNewswire 6/13 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharma...

GlobeNewswire 6/13 Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Director...

GlobeNewswire 6/13 SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Marinus Pharmac...

GlobeNewswire 6/13 American Kidney Fund Convenes Rare Kidney Disease Action Network to Advocate for Policies and Regula...

GlobeNewswire 6/13 Novartis' Fabhalta Shows Promise in Addressing Critical Gaps in C3 Glomerulopathy Treatment

GlobeNewswire 6/12 Investment Opportunity: PlantForm Corporation Seeks $25M to Accelerate Plant-Based Medical Breakthro...

GlobeNewswire 6/11 SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emuls...

GlobeNewswire 6/11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...

GlobeNewswire 6/11 60 Degrees Pharmaceuticals Receives FDA Orphan Drug Designation for Tafenoquine for Treatment of Pat...

GlobeNewswire 6/11 NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients

GlobeNewswire 6/11 Alvotech and STADA add to strategic alliance through denosumab partnership

GlobeNewswire 6/11 NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients

GlobeNewswire 6/11 ROSEN, A LONGSTANDING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel...

GlobeNewswire 6/10 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...

GlobeNewswire 6/10 Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus He...

GlobeNewswire 6/6 BioNTX Announces 10th Annual iC³® Life Science & Healthcare Innovation Summit

GlobeNewswire 6/6 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...

GlobeNewswire 6/6 Qubit Pharmaceuticals selected as one of the 100 Technology Pioneers 2024 by the World Economic For...

Santhera Pharmaceuticals Holding .../ CH1276028821 /

If you wish to receive reply to your feedback, please provide your email address.